Topical JAK1/JAK2 Inhibitor Ruxolitinib trials about to recruit

Hey All,

I emailed Incyte (manufacture of Ruxolitinib) on 8th September to ask whether they would consider the topical form of this jak1/jak2 for Alopecians. And surprise surprise by coincidence they are actually!! 

https://clinicaltrials.gov/ct2/show/NCT02553330?term=Incyte+alopeci...

The good thing is that the sponsor is Incyte self (so no bullsh*t about funding) and they will start recruiting soon!

All the best everybody and keep fighting!

Views: 592

▶ Reply to This

Replies to This Discussion

Permalink Reply by singh on September 23, 2015 at 6:08am
This is great news! Am from the UK so I couldn't participate ! But whoever does please keep us all updated as soon as! Exciting stuff !
Permalink Reply by gatesm on September 23, 2015 at 12:54pm

Wow exciting! Any idea when it opens?

Permalink Reply by 3ebdie on September 23, 2015 at 1:40pm

Estimated Enrollment:68

Study Start Date:October 2015

Estimated Study Completion Date:January 2019

Estimated Primary Completion Date:May 2018 (Final data collection date for primary outcome measure)

Permalink Reply by singh on September 23, 2015 at 1:47pm
3 years just see the primary !!! :/
Permalink Reply by serg navaro on September 23, 2015 at 4:48pm
Hmmm wonder if they would consider someone already on xeljanz. I see there's a location here in Houston so I will call and see what they say :)

RSS

Disclaimer

Any mention of products and services on Alopecia World is for informational purposes only; it does not imply a recommendation or endorsement by Alopecia World. Nor should any statement or representation on this site be construed as professional, medical or expert advice, or as pre-screened or endorsed by Alopecia World. Alopecia World is not responsible or liable for any of the views, opinions or conduct, online or offline, of any user or member of Alopecia World.

© 2024   Created by Alopecia World.   Powered by

Badges  |  Report an Issue  |  Terms of Service